Charles Schwab’s Adeptus Health Inc ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-22,300
Closed -$41K 3210
2017
Q1
$41K Sell
22,300
-34,856
-61% -$196K ﹤0.01% 3046
2016
Q4
$437K Sell
57,156
-408
-0.7% -$7.5K ﹤0.01% 2704
2016
Q3
$2.48M Buy
57,564
+11,552
+25% +$521K ﹤0.01% 2035
2016
Q2
$2.38M Buy
46,012
+10,510
+30% +$630K ﹤0.01% 1981
2016
Q1
$1.97M Buy
35,502
+21,108
+147% +$1.09M ﹤0.01% 2050
2015
Q4
$785K Sell
14,394
-6,507
-31% -$415K ﹤0.01% 2471
2015
Q3
$1.69M Buy
20,901
+12,801
+158% +$1.32M ﹤0.01% 2164
2015
Q2
$770K Hold
8,100
﹤0.01% 2526
2015
Q1
$407K Hold
8,100
﹤0.01% 2710
2014
Q4
$303K Buy
+8,100
New +$255K ﹤0.01% 2840

Other funds holding ADPT

Charles Schwab's ADPT Position: Q2 2017 in Review

Charles Schwab sold out of Adeptus Health Inc (ADPT) in Q2 2017, closing a stake of 22,300 shares — an estimated $41K sold.

Charles Schwab first reported a position in ADPT in Q4 2014 and held it in 10 quarters. The position peaked at $2.48M in Q3 2016. 9 funds tracked by Wall St. Rank hold ADPT as of Q2 2017.

  • Charles Schwab reported no remaining Adeptus Health Inc position as of Q2 2017 after selling out during the quarter.
  • Charles Schwab sold 22,300 Adeptus Health Inc shares in Q2 2017, an estimated $41K.
  • Charles Schwab first reported a position in Adeptus Health Inc in Q4 2014 and held it in 10 quarters.
  • Charles Schwab's Adeptus Health Inc position peaked at $2.48M in Q3 2016.
  • 9 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q2 2017.

Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.